Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
Publication Number | Title | Priority Date |
---|---|---|
WO-2022056281-A1 | Protein tyrosine phosphatase inhibitors and methods of use thereof | 2020-09-11 |
WO-2021203014-A1 | Pyrano[4,3-b]l ndole derivatives as alpha-1 -antitrypsin modulators for treating alpha-1 -antitrypsin deficiency (aatd) | 2020-04-03 |
WO-2021203023-A1 | Indole derivatives as alpha-1 -antitrypsin modulators for treating alpha-1 -antitrypsin deficiency (aatd) | 2020-04-03 |
WO-2021173917-A1 | Inhibitors of receptor interacting protein kinase i for the treatment of disease | 2020-02-28 |
WO-2021127499-A1 | Protein tyrosine phosphatase inhibitors and methods of use thereof | 2019-12-18 |
WO-2021117767-A1 | Method for producing nitrogen-containing heteroarylcarboxamide acetic acid derivative | 2019-12-10 |
WO-2021105117-A1 | Substituted aminoquinolones as dgkalpha inhibitors for immune activation | 2019-11-28 |
CN-112830919-A | Benzopiperidine derivatives as pharmaceutical agents and process for preparing them | 2019-11-22 |
US-2021115065-A1 | Compounds and compositions for the treatment of parasitic diseases | 2019-10-21 |
WO-2021067670-A1 | Process for preparing an activin receptor-like kinase inhibitor | 2019-10-02 |